Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Phase II Study of Fraility Index and Geriatric Assessment as Predictors of Toxicity to Front-Line Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer

Authors not listed

Wake Forest University Health Sciences · 2010

Mitochondrial dysfunction Human Randomized controlled trial

Abstract

This phase II trial is studying how well a frailty index and geriatric assessment works in predicting toxicity to front-line chemotherapy in treating patients with stage IV non-small cell lung cancer. A frailty index and geriatric assessment prior to treatment may help identify a better treatment regimen

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-21 MST

Cite this

APA

Anonymous. (2010). A Phase II Study of Fraility Index and Geriatric Assessment as Predictors of Toxicity to Front-Line Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer. <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT01026467

Vancouver

Anonymous. A Phase II Study of Fraility Index and Geriatric Assessment as Predictors of Toxicity to Front-Line Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer. Wake Forest University Health Sciences. 2010.

BibTeX

@misc{anon2010APhase, title = {A Phase II Study of Fraility Index and Geriatric Assessment as Predictors of Toxicity to Front-Line Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer}, author = {Anonymous}, journal = {Wake Forest University Health Sciences}, year = {2010}, }